Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 585-589

  Cui, Jian Qi ^a   Wang, Huichen ^a   Reddy, E Shyam P ^a   Rao, Veena N ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

BRCA1a; BRCA1b; Breast cancer; Transcriptional activation; Zinc finger

Indexed keywords

BRCA1 PROTEIN; BRCA1A PROTEIN; BRCA1B PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; FEMALE; GENE ISOLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA SPLICING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0031958724     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.585     Document Type: Article

References (40)

1. Futreal PA, Liu Q, Shatluck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, et al: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, 1994.
2. Hall JM, Lee MK, Newman B, Morrow JE, Andersen LA, Huey B and King MC: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689, 1990.
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994.
4. Neuhausen SL and Marshall CJ: Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. Cancer Res 54: 6069-6072, 1994.
5. Smith SA, Hasten DF, Evans DG and Ponder BA: Allele losses in the region 17q 12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 2: 128-131, 1992.
6. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T. Averill D, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090, 1994.
7. Chapman MS and Verma IM: Transcriptional activation by BRCA1. Nature 382: 678-679, 1996.
8. Monteiro AN, August A and Hanafusa H: Evidence for a transcriptional activation function of BRCA1 C-terminal region Proc Natl Acad Sci USA 93: 13595-13599, 1996.
9. Milner J, Ponder B, Hughes-Davies L, Seitmann M and Kouzarides T: Transcriptional activation functions in BRCA2. Nature 386: 772-773, 1997.
10. Lane TF, Deng C, Elson A, Lyu MS, Kozak CA and Leder P: Expression of BRCA1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 9: 2712-2722, 1995.
11. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin G-Y, Abel KJ, Weber BL and Chodosh LA: The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11: 17-26, 1995.
12. Abel KJ, Xu J, Yin G-Y, Lyons RH, Meisler MH and Weber BL: Mouse BRCA1: localization sequence analysis and identification of evolutionary conserved domains. Hum Mol Genet 4: 2265-2273, 1995.
13. Sharan SK, Wims M and Bradley A: Murine BRCA1: sequence and significance for human missense mutations. Hum Mol Genet 4: 2275-2278, 1995.
14. Gowen LC, Johnson BL, Latour AM, Sulik KK and Koller BH: BRCA1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 12: 191-194, 1996.
15. Hakem R, de la Pomba JL, Sirard C, Mo R, Woo M. et al: The tumor suppressor gene BRCA1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009-1023, 1996.
16. Liu CY, Flesken-Nikitin A, Li S, Zeng Y and Lee WH: Inactivation of the mouse BRCA1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 10. 1835-1843, 1996.
17. Chen Y, Chen C-F, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK and Lee WH: Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791, 1995.
18. Rao VN, Shao N, Ahmad M and Reddy ESP: Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene 12: 523-528, 1996.
19. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S and Livingston DM: Location of BRCA1 in human breast and ovarian cancer cells. Science 272: 123-125, 1996.
20. Wang H, Shao N, Ding QM, Cui JQ, Reddy ESP and Rao VN: BRCA1 proteins are transported to the nucleus in the-absence of serum and splice variants BRCAla, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15: 143-157, 1997.
21. Zhang HT, Zhang X, Zhao HZ, Kajino Y, Weber BL, Davis JG, Wang Q, O'Rourke DM, Zhang HB, Kajino K and Greene MI: Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14: 2863-2869, 1997.
22. Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL and Lee WH: BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 56: 3168-3172, 1996.
23. Scully R, Chen J, Plug A, Xiao Y, Weaver D, et al: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275, 1997.
24. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM and Baer R: Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 14: 430-440, 1996.
25. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, and Livingston DM: Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90: 425-435, 1997.
26. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga, CL, King MC and Jensen RA: Growth retardation and tumour inhibition by BRCA1. Nat Genet 12: 298-302, 1996.
27. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9: 444-450, 1995.
28. Shao N, Chai YL, Reddy ES and Rao VN: Induction of apoptosis by the tumor suppressor protein BRCA1. Oncosene 13: 1-7, 1996.
29. Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB and Weber BL: Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17: 444-452, 1997.
30. Wilson CA, Payton MM, Elliott GS, Buaas FW, Cajulis EE, Grosshans D, Ramos L, Reese DM, Slamon DJ and Calzone FJ: Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta 1 1b. Oncogene 14: 1-16, 1997.
31. Webster N, Jin JR, Green S, Hollis M and Chambon P: The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52: 169-178, 1988.
32. Rao VN, Huebner K, Isobe M, Al-Rushdi A. Croce CM and Reddy ESP: Elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science 244: 66-70, 1989.
33. Rao VN and Reddy ESP: Delta elk-1, a variant of elk-1, fails to interact with the serum response factor and binds to DNA with modulated specificity. Cancer Res 53: 215-220, 1993.
34. Marias R, Wynne and Treisman R: The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381-393, 1993.
35. Bhattacharya G, Lee L, Reddy ESP and Rao VN: Transcriptional activation domains of elk-1, delta elk-1 and SAP-1 proteins. Oncogene 8: 3459-3464, 1993.
36. Oliner JD, Pietenpol JA, Thiagulingam S, Gyuris J, Kinzler KW and Vogelstein B: Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860, 1993.
37. Leuther KK and Johnston SA: Non-dissociation of GAL4 and GAL80 in vivo after galactose induction. Science 256: 1333-1335, 1992.
38. Ma J and Ptashne M: The carboxy-terminal 30 amino acids of GAL4 are recognized by GAL80. Cell 50: 137-142, 1987.
39. Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, Livingston DM and Parvin JD: BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 94: 5605-5610, 1997.
40. Shattuck-Eiden D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erods M, Brody L, Freidmen L, Ostermeyer E, Szabo C, King MC, et al: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening. JAMA 273: 535-541, 1995.